Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F M Muggia

Showing results (241-250 of 317) with videos related to

Pageof 32
Sort By:
Seminars in Oncology|August 1, 1995
Paclitaxel 3-hour infusion given alone and combined with carboplatin: preliminary results of dose-escalation trialsF M Muggia, D Vafai, R Natale, et al.
European Journal of Cancer|February 1, 1981
Current results of the screening program at the Division of Cancer Treatment, National Cancer InstituteA Goldin, J M Venditti, J S Macdonald, et al.
Cancer Investigation|January 1, 1995
Phase II clinical trial of carboplatin, ifosfamide, with oral mesna for metastatic breast carcinomaM Turrill, D V Spicer, A S Kelley, et al.
American Journal of Clinical Oncology|October 1, 1985
A phase II study of bisantrene in advanced refractory breast cancer. An Eastern Cooperative Oncology Group pilot studyK J Pandya, F M Muggia, R T Skeel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 5, 2003
Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactionsA Chanan-Khan, J Szebeni, S Savay, et al.
Cancer Treatment Reports|November 1, 1979
Analysis and interpretation of response rates for anticancer drugsY J Lee, R Catane, M Rozencweig, et al.
Cancer|July 1, 1988
Toxicity comparisons between two chemotherapy regimens as adjuvant or salvage treatment in nonseminomatous testicular cancerR B Weiss, D M Stablein, F M Muggia, et al.
Anti-Cancer Drugs|July 19, 2001
Phase I and pharmacologic study of i.v. hydroxyurea infusion given with i.p. 5-fluoro-2'-deoxyuridine and leucovorinA A Garcia, F M Muggia, C P Spears, et al.
Investigational New Drugs|January 1, 1986
Oral 4-demethoxydaunorubicin (idarubicin) in bronchogenic lung cancer; phase II trialH S Hochster, M D Green, R H Blum, et al.
European Journal of Cancer|November 1, 1977
ICRF-159: current status and clinical prospectsR E Bellet, M Rozencweig, D D Von Hoff, et al.
Pageof 32

Showing results (241-250 of 317) with videos related to

Sort By:
Pageof 32
Seminars in Oncology|August 1, 1995
Paclitaxel 3-hour infusion given alone and combined with carboplatin: preliminary results of dose-escalation trialsF M Muggia, D Vafai, R Natale, et al.
European Journal of Cancer|February 1, 1981
Current results of the screening program at the Division of Cancer Treatment, National Cancer InstituteA Goldin, J M Venditti, J S Macdonald, et al.
Cancer Investigation|January 1, 1995
Phase II clinical trial of carboplatin, ifosfamide, with oral mesna for metastatic breast carcinomaM Turrill, D V Spicer, A S Kelley, et al.
American Journal of Clinical Oncology|October 1, 1985
A phase II study of bisantrene in advanced refractory breast cancer. An Eastern Cooperative Oncology Group pilot studyK J Pandya, F M Muggia, R T Skeel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 5, 2003
Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactionsA Chanan-Khan, J Szebeni, S Savay, et al.
Cancer Treatment Reports|November 1, 1979
Analysis and interpretation of response rates for anticancer drugsY J Lee, R Catane, M Rozencweig, et al.
Cancer|July 1, 1988
Toxicity comparisons between two chemotherapy regimens as adjuvant or salvage treatment in nonseminomatous testicular cancerR B Weiss, D M Stablein, F M Muggia, et al.
Anti-Cancer Drugs|July 19, 2001
Phase I and pharmacologic study of i.v. hydroxyurea infusion given with i.p. 5-fluoro-2'-deoxyuridine and leucovorinA A Garcia, F M Muggia, C P Spears, et al.
Investigational New Drugs|January 1, 1986
Oral 4-demethoxydaunorubicin (idarubicin) in bronchogenic lung cancer; phase II trialH S Hochster, M D Green, R H Blum, et al.
European Journal of Cancer|November 1, 1977
ICRF-159: current status and clinical prospectsR E Bellet, M Rozencweig, D D Von Hoff, et al.
Pageof 32